Toxoplasma gondii surface antigen 1 (SAG1) as a potential candidate to develop vaccine against toxoplasmosis: A systematic review
InfectologiaSobre o estudo
- Desenho
- Revisão sistemática
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- Comparative immunology, microbiology and infectious diseases
- Publicado em
- 7 jan 2020
- Citações
- 0
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Toxoplasma gondii surface antigen 1 (SAG1) as a potential candidate to develop vaccine against toxoplasmosis: A systematic review
Abdol Sattar Pagheh, Shahabeddin Sarvi, Mehdi Sharif, Fatemeh Rezaei, Ehsan Ahmadpour, Samira Dodangeh, Zahra Omidian, Hadi Hassannia, Saeed Mehrzadi, Ahmad Daryani
Descritores MeSH
- Toxoplasmosis
- Protozoan Proteins
- Protozoan Vaccines
- Antigens, Protozoan
- Toxoplasma
- Vaccines, DNA
- Adjuvants, Immunologic
- Mice
- Animals
- Disease Models, Animal
Veja também
Estudos relacionados
- Can a DNA vaccine protect against Chagas disease? A systematic review of preclinical studies
- Advancing protozoan vaccine research: A review of promising candidates and emerging technologies
- Toxoplasma gondii and a Cancer Biology Dichotomy: A Systematic Review of Experimental Studies of Its Antitumor and Pro-Tumor Effects
- Human responses to the DNA prime/chimpanzee adenovirus (ChAd63) boost vaccine identify CSP, AMA1 and TRAP MHC Class I-restricted epitopes